Clinical trial
REX - A Pilot Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
NCT02921542 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REX - A Pilot Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
- Lead sponsor
- Spectranetics Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 15, 2016
- Completion date
- May 1, 2019
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.